VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) — EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), announced today that Mr. Morten Borch and Mr. Bobby Doyon have both resigned as members of the Board of Directors.
Mr. Borch is reducing his general business and board commitments currently. Mr. Doyon wishes to focus his time and efforts on his professional duties and commitments. Both directors were planned, and had accepted, to be vacating their board seats at the company upon the planned closing of the proposed business combination with Global Cannabinoids.
EXM and the Board are currently evaluating candidates with respect to appointing two new independent directors to fill the two current vacancies.
The Board of Directors would like to thank both Mr. Borch and Mr. Doyon for their meaningful contribution over the past few years and wish them well in all their future endeavors.
ON BEHALF OF THE BOARD OF DIRECTORS OF EXMCEUTICALS INC.
Jonathan Summers, Chairman and Chief Executive Officer
For further information, contact:
Investor Relations
Email: investors@exmceuticals.com
FOR MORE UPDATES ON THE COMPANY
Follow us on Twitter: https://twitter.com/EXMceuticals
Follow us on LinkedIn: https://www.linkedin.com/company/exmceuticalsinc/
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…